期刊文献+

CXCR4慢病毒载体的构建及其在人脐带血间充质干细胞的表达 被引量:1

Construction of Lentiviral Expression Vector of CXCR4 and Its Expression in Human Umbilical Cord Mesenchymal Stem Cell
原文传递
导出
摘要 目的:构建趋化因子CXC亚族CXCR4的慢病毒表达载体并观察其转染人脐带间充质干细胞后的表达。方法:用逆转录PCR方法获取CXCR4基因编码区片段,将构建的慢病毒载体质粒pLVTHM-EGFP-CXCR4与包装质粒psPAX2和包膜质粒pMD2.G共转染293T细胞,包装生产慢病毒。用相同滴度的慢病毒转导等量间充质干细胞(Mesenchymal Stem Cell,MSCs),后采用Real time PCR检测CXCR4 mRNA、Western Blot方法检测蛋白质的表达。结果:PCR、酶切和测序结果表明成功的构建了CXCR4基因重组慢病毒载体。同时用该慢病毒载体转染MSCs后可有效地增加MSCs中CXCR4的表达。结论:成功构建了CXCR4的慢病毒表达载体并能在MSCs中表达,为进一步研究其在干细胞移植中的应用奠定基础。 Objective: To construct the lentiviral expression vector of CXCR4 and study the expression in human umbilical cord mesenchymal stem cell (hUCMSCs). Methods: A reverse transcription-polymerase chain reaction (RT-PCR) was performed to get CX- CR4 gene code fragment, 293T cells were co-transfected with lentiviral expression vector of CXCR4, psPAX2 packaging plasmid and pMD2.G. The plasmid was coated to pack lentivirus. Then lentiviral expression vector of CXCR4 were co-transfected with hUCMSCs and the expression of CXCR4 mRNA and protein expression level were detected by RT-PCR and western blot respectively. Results: By means of sequencing, restriction endonuelease analysis and PCR, lentiviral expression vector of CXCR4 has been successfully constructed. lentiviral expression vector of CXCR4 co-transfected with hUCMSCs can effectively increase the expression of CXCR4 in MSCs. Conclusions: Lentiviral expression vector of CXCR4 co-transfected with hUCMSCs has been successfully constructed, which can be applied to further research of MSCs.
出处 《现代生物医学进展》 CAS 2013年第28期5429-5432,共4页 Progress in Modern Biomedicine
关键词 慢病毒 人脐带间充质干细胞 基因重组 CXCR4 Lentiviral Human umbilical cord mesenchymal stem cell Gene construction CXCR4
  • 相关文献

参考文献1

二级参考文献32

  • 1Remuzzi G, Schieppati A, Ruggenenti E Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346: 1145-1151.
  • 2Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G.Lowenfels AB, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000; 35: 157-165.
  • 3Group UKPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
  • 4Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; 359: 1565-1576.
  • 5Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
  • 6Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
  • 7Yamagishi S, Fukami K, Ueda S, Okuda S. Molecular mechanism of diabetic nephropathy and its therapeutic intervention. Current Drug Targets 2007; 8: 952-959.
  • 8Prockop DJ. Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997; 276: 71-74.
  • 9Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
  • 10Digirolamo CM, Stokes D, Colter D, Phinney DG,Class R,Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with greatest potential to propagate and differentiate. Br J Haematol 1999; 107:275-281.

共引文献14

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部